Expression, Purification, and Characterization of the Immunological Response to a 40-KilodaltonPlasmodium vivaxTryptophan-Rich Antigen
Open Access
- 1 June 2008
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 76 (6) , 2576-2586
- https://doi.org/10.1128/iai.00677-07
Abstract
We describe here an ∼40-kDaPlasmodium vivaxtryptophan-rich antigen (PvTRAg40) which contains 321 amino acids and 11.4% tryptophan residues. This protein shows 65% homology (35% identity) with the previously described PvTRAg, besides sharing 23 of 27 positionally conserved tryptophan residues and similar genomic organization. The nucleotide sequence of the entire tryptophan-rich domain of PvTRAg40 was identical among 35P. vivaxclinical isolates. The protein is expressed by ring, trophozoite, and schizont stages of the parasite. The cDNA covering exon 2 of PvTRAg40 was cloned and expressed in the pPROEXHTa vector, and recombinant protein was purified. A high humoral immune response (90.7% seropositivity;n= 43) against this recombinant protein was detected in humans during the course of naturalP. vivaxinfection. Eighty percent of the total of 20P. vivax-exposed individuals exhibited lymphoproliferative responses against this antigen. The T cells of these individuals produced larger amounts of interleukin-12 (IL-12), IL-4, and IL-10 than gamma interferon and tumor necrosis factor alpha cytokines in response to the recombinant protein. Production of Th2-biased cytokines, conserved T- and B-cell epitopes, and an enhanced humoral immune response indicate that PvTRAg40 could possibly induce antibody-mediated immune protection against infection.Keywords
This publication has 33 references indexed in Scilit:
- Expression and purification of a Plasmodium vivax antigen – PvTARAg55 tryptophan- and alanine-rich antigen and its immunological responses in human subjectsVaccine, 2007
- Extensive heterozygosity at four microsatellite loci flanking Plasmodium vivax dihydrofolate reductase geneMolecular and Biochemical Parasitology, 2007
- Similar Trends of Pyrimethamine Resistance-Associated Mutations in Plasmodium vivax and P. falciparumAntimicrobial Agents and Chemotherapy, 2007
- Genetic vaccination approaches against malaria based on the circumsporozoite proteinWiener klinische Wochenschrift, 2006
- Malaria in the post-genomics era: light at the end of the tunnel or just another train?Published by BMJ ,2005
- Genes coding for tryptophan-rich proteins are transcribed throughout the asexual cycle of Plasmodium falciparumZeitschrift Fur Parasitenkunde-Parasitology Research, 2005
- Immunity to Asexual Blood Stages of Plasmodium: Is Resistance to Acute Malaria Adaptive or Innate?Parasitology Today, 1998
- T Cell Responses to Pre-Erythrocytic Stages of Malaria: Role in Protection and Vaccine Development Against Pre-Erythrocytic StagesAnnual Review of Immunology, 1993
- Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible miceClinical and Experimental Immunology, 1993
- Non-CS pre-erythrocytic protective antigensImmunology Letters, 1990